Pre-eclampsia and cardiovascular risk: a follow-up study of the GenPE population in Colombia

Authors

  • Norma Cecilia Serrano-Díaz
  • María Carolina Páez-Leal
  • Mónica Andrea Beltrán-Avendaño
  • Claudia Carolina Colmenares-Mejìa
  • Elizabeth Guio-Mahecha
  • Paula Bautista-Niño
  • Colaboradores Lista completa al final del documento

DOI:

https://doi.org/10.18597/rcog.177

Keywords:

Pre-eclampsia, obesity, dyslipidemia, metabolic syndrome, cardiovascular disease, cardiovascular risk

Abstract

Introduction: Females having a background of pre-eclampsia (PE) are at greater risk of developing cardiovascular disease. The GenPE study has captured pregnant females with and without PE in Colombia during the last 10 years, making it possible today to evaluate cardiovascular outcomes in this group.

Objective: Determining the presence of cardiovascular disease in young females who were and were not exposed to preclampsia and who were recruited by the GenPE study carried out in Bucaramanga, Colombia.

Materials and methods: This was a cohort study which included 106 primiparous patients aged less than 26 years old having no background of chronic disease taken from an original cohort of 666 patients (2005-2010). They were physically examined and venopuncture was made for glycemia, lipid profile, uric acid and apolypoprotein A-I and B. The presence of hypertension, obesity, type 2 diabetes mellitus and metabolic syndrome were evaluated. Differences were established by Wilcoxon or Chisquared tests (relative risk and 95% CI) between females who had been exposed to PE and those who had not been so and the change between entering the GenPE study and the first follow-up.

Results: An association was found between exposure to PE and having higher diastolic pressure figures (p = 0.003) and hypercholesterolemia (p = 0.040). Sub-optimal HDL cholesterol and apo A-I levels were found in the whole population. No association with strong outcomes was found during the first follow-up, such as hypertension, obesity, type 2 diabetes mellitus or metabolic syndrome.

Conclusion: Changes in peripheral arterial disease (PAD) and cardiovascular risk-associated biomarkers became evident in a sample of young colombian females who developed PE during the first followup within 2 years after delivery.

Author Biographies

Norma Cecilia Serrano-Díaz

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

María Carolina Páez-Leal

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

Mónica Andrea Beltrán-Avendaño

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

Universidad Industrial de Santander (UIS). Bucaramanga, Colombia.

Claudia Carolina Colmenares-Mejìa

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

Elizabeth Guio-Mahecha

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

Paula Bautista-Niño

Centro de Investigaciones Biomédicas, Universidad Autónoma de Bucaramanga (UNAB). Bucaramanga, Colombia.

Colaboradores Lista completa al final del documento

Lista completa al final del documento

References

World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic Variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1998;158:80-3.

Khan K, Wojdyla D, Say L, Gülmezoglu A, van Look P. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.

Hogan M, Foreman K, Naghavi M, Ahn S, Wang M, Makela S, et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23.

Lykke J, Langhoff-Roos J, Sibai B, Funai E, Triche E, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009; 53:944-51.

McDonald S, Malinowski A, Zhou Q, Yusuf S, Devereaux P. Cardiovascular squealed of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J 2008;156:918-30.

Valdes G, Quezada F, Marchant E, Schultzendorff A, Moran S, Padilla O, et al. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension 2009;53:733-8.

Garovic V, Baileyb K, Boerwinklec E, Huntd S, Wedere A, Curb D, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens 2010;28:826-33.

Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (Champs): population-based retrospective cohort study. Lancet 2005;366:1797-803.

Qiu C, Williams M, Leisenring W, Sorensen T, Frederick I, Dempsey JC, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 2003;41:408-13.

Girouard J, Giguère Y, Moutquin J, Forest JC. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007;49:1056-62.

Roberts J, Gammill H. Insulin resistance in preeclampsia. Hypertension 2006;47;341-2.

Poston L. Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 2006;58 Suppl:69-74.

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.

Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2008;14:802-3.

Bertoni AG, Bonds DE, Steffes S, Jackson E, Crago L, Balasubramanyam A, et al. Quality of cholesterol screening and management with respect to the National Cholesterol Education’s Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina. Am Heart J 2006;152:785-92.

American Psychiatric Association. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Health Disorders, 4th ed; 2000.

Rabe-Hesketh S, Skrondal A. Multinivel and longitudinal modeling using Stata. Volume I: Continues responses. 3th ed. College Station: Stata Press; 2012.

Adams E, MacGillvray I. Long term effect of preeclampsia on blood pressure. Lancet 1961;2:1373-5.

Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.

Encuesta Nacional de Demografía y Salud 2010. Capítulo V – Fecundidad, pp. 108-126.

Ruiz JS. Maternal Mortality and Morbidity Related to Hypertensive Disorders During Pregnancy. (Tesis Maestría). Stockholm: Demography Unit, Department of Sociology, Stockholm University; 2012.

How to Cite

1.
Serrano-Díaz NC, Páez-Leal MC, Beltrán-Avendaño MA, Colmenares-Mejìa CC, Guio-Mahecha E, Bautista-Niño P, et al. Pre-eclampsia and cardiovascular risk: a follow-up study of the GenPE population in Colombia. Rev. colomb. obstet. ginecol. [Internet]. 2012 Sep. 30 [cited 2024 May 17];63(3):241-5. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/177

Downloads

Download data is not yet available.

Published

2012-09-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: